Aemetis, Inc
AMTX Nasdaq· Industrial Organic Chemicals
Last close · Oct 23, 2026
$1.30
KIRA · Stoqly’s AI analyst, in plain words
- Aemetis, Inc had $198M of revenue in fiscal 2025, down 26.2% on the year before. Over five years, revenue changed +3.6% a year on average.
- Its operating margin was −18.8%, down 3.7 pts: of every 100 in sales, about −19 is left after running the business.
- Aemetis, Inc lost $77.0M in fiscal 2025.
- Free cash flow was −$22.7M in fiscal 2025, −11.5% of revenue.
- Aemetis, Inc owes $380M more than it holds in cash.
Market cap
$92.2M
P/E
—
Revenue
$198M
Net income
−$77.0M
Free cash flow
−$22.7M
Operating margin
−18.8%
Aemetis, Inc in 30 seconds · fiscal 2025
Are sales growing?
−26.2%
No. Sales fell 26.2% last year.
Does it make a profit?
−39.0%
No. It lost money last year.
Does profit turn into cash?
−11.5%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 9
Weak. It passes 3 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Aemetis, Inc does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 16, 2026
- Legal name
- AEMETIS, INC
- CIK
- 0000738214
Aemetis, Inc · AMTX
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $212M | $28.1M | $77.2M | $268M | $198M |
| Revenue growth | 28.0% | −86.7% | 174.6% | 246.7% | −26.2% |
| Gross margin | 3.7% | −19.7% | 2.6% | −0.2% | −0.4% |
| Operating margin | −7.5% | −122.4% | −48.5% | −15.1% | −18.8% |
| Net income | −$47.1M | −$108M | −$46.4M | −$87.5M | −$77.0M |
| Net margin | −22.2% | −383.3% | −60.1% | −32.7% | −39.0% |
| Diluted EPS | −$1.54 | −$3.12 | −$1.22 | −$1.91 | −$1.28 |
| Cash | |||||
| Cash from operations | −$20.6M | −$22.9M | $13.8M | −$32.9M | $3.3M |
| Capital expenditure | $26.7M | $39.2M | $33.1M | $20.3M | $26.0M |
| Free cash flow | −$47.3M | −$62.0M | −$19.3M | −$53.2M | −$22.7M |
| FCF margin | −22.3% | −220.6% | −25.0% | −19.9% | −11.5% |
| Share count change | 46.0% | 12.7% | 10.1% | 20.6% | 30.7% |
| Debt and strength | |||||
| Cash and short-term investments | $7.8M | $4.3M | $2.7M | $0.9M | $4.9M |
| Debt incl. finance leases | $206M | $286M | $321M | $368M | $385M |
| Shareholders' equity | −$120M | −$202M | −$217M | −$264M | −$307M |
| Current ratio | 0.3x | 0.2x | 0.4x | 0.3x | 0.1x |
| Interest coverage | −0.7x | −1.2x | −0.9x | −0.9x | −0.7x |
| Returns and quality | |||||
| Return on capital | −16.4% | −35.4% | −30.0% | −31.9% | −42.0% |
| Piotroski F-score | 3 | 1 | 7 | 2 | 3 |
| Altman Z'' | −9.4 | −10.6 | −9.2 | −11.2 | −18.3 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
1 insider
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Aemetis, Inc · AMTX
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.30 a share, the company is worth $92.2M.
Source: SEC EDGAR XBRL filings (CIK 0000738214). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.